Carpio, Marjorie B.
HRN: 26-79-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2025
CEFTAZIDIME 1GM (VIAL)
03/17/2025
03/24/2025
IV
1g
Q8H
Decompensated Heart Failure, R/o Septic Shock
Waiting Final Action
Indication: Empiric Type of Infection: Cardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes